A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T

Clinical trial NCT05468190 · UNKNOWN

Trial details

NCT number: NCT05468190
Sponsor: Chongqing Precision Biotech Co., Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Tumor Advanced Solid Tumor Renal Cell Carcinoma Ovarian Cancer Cervix Cancer

Start date: 2022-07-17
Primary completion: 2024-07-17
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.